Streetbeat News

Products Services

YUM

Yum! Brands, Inc. (NYSE:YUM) reported mixed Q2 results with adjusted EPS of $1.35 beating estimates but revenues missing expectations. Despite a 1% decline in same-store sales, the company saw a 4% revenue increase and a 10% rise in core operating profit. Digital sales surged to nearly $8 billion. CEO David Gibbs highlighted an 8% profit growth target and expansion in digital and AI technology.

Portfolio Pulse from Nabaparna Bhattacharya

August 06, 2024 | 2:42 pm

KKR

Körber Supply Chain Software, a joint venture between Körber AG and KKR, has signed a binding agreement to acquire MercuryGate International Inc., a leading provider of transportation management systems. This acquisition aims to enhance Körber's supply chain execution solutions, offering increased flexibility, scalability, and resiliency to customers.

Portfolio Pulse from Benzinga Newsdesk

August 06, 2024 | 2:31 pm

GOOGL

MGNI

NFLX

TTD

Netflix is lowering its ad prices to between $20 and $30 CPM, making it more competitive in the streaming ad market. This move comes as Netflix partners with adtech firms like The Trade Desk, Google's Display & Video 360, and Magnite to expand its programmatic advertising capabilities.

Portfolio Pulse from Benzinga Newsdesk

August 06, 2024 | 2:24 pm

AHOY

EQTY

J

Jacobs Solutions Inc. (NYSE:J) reported strong Q3 FY24 results, with revenue of $4.23 billion beating expectations and adjusted EPS of $1.96 meeting consensus. The company highlighted significant strides in portfolio optimization and strong bookings and backlog. Jacobs reiterated its FY24 adjusted EBITDA outlook and slightly revised its adjusted EPS outlook. Investors can gain exposure to Jacobs through Tidal ETF Trust Newday Ocean Health ETF (NYSE:AHOY) and Valued Advisers Trust Kovitz Core Equity ETF (NYSE:EQTY).

Portfolio Pulse from Lekha Gupta

August 06, 2024 | 2:20 pm

RIVN

Rivian has announced a limited-time 2.99% financing offer on its new Dual Max R1S model. This move is likely aimed at boosting sales and attracting more customers to its electric SUV lineup.

Portfolio Pulse from Benzinga Newsdesk

August 06, 2024 | 2:15 pm

NVDA

Nvidia has postponed the launch of its new AI chip, the Blackwell B200, due to a design flaw, causing a 35% drop in its stock price from June to August 2024. The delay impacts major cloud service providers like Microsoft, Google, and Meta. Despite the setback, Nvidia remains optimistic about future production and has seen a year-to-date growth of 102%.

Portfolio Pulse from Zaheer Anwari

August 06, 2024 | 2:14 pm

ZCAR

Zoomcar has launched a unified app to enhance the car-sharing experience for both guests and hosts, replacing its previous two-app system. The new app includes over 10 feature upgrades aimed at boosting platform growth and user satisfaction.

Portfolio Pulse from Benzinga Newsdesk

August 06, 2024 | 2:13 pm

ANAB

Over the past three months, four analysts have shared their insights on AnaptysBio (NASDAQ:ANAB), with ratings ranging from bullish to bearish. The average 12-month price target has increased by 26.79% to $53.25. Analysts from HC Wainwright & Co., JP Morgan, and Wedbush have maintained or raised their ratings and price targets. AnaptysBio is a clinical-stage biotechnology company focused on developing antibody product candidates for autoimmune and inflammatory diseases.

Portfolio Pulse from Benzinga Insights

August 06, 2024 | 2:01 pm

IONQ

IonQ has secured a $5.7 million contract with ARLIS to design a multi-node blind quantum computing system. This project extends IonQ's work with the federal government on quantum initiatives and includes future phases for construction, delivery, and maintenance. ARLIS will also research the cybersecurity of multi-party quantum computation.

Portfolio Pulse from Benzinga Newsdesk

August 06, 2024 | 2:01 pm

BAX

Baxter International Inc (NYSE:BAX) reported strong Q2 results, beating both EPS and sales expectations. The company raised its annual outlook, driven by growth across all segments, particularly in Pharmaceuticals and Medical Products & Therapies. Baxter also provided updated guidance for 2024 and Q3, expecting continued growth. The stock rose 6.47% following the announcement.

Portfolio Pulse from Vandana Singh

August 06, 2024 | 1:59 pm